baber/WOPTO huggingface dataset:
Patent NZ-552500-A (NZ)
Title: Clamping apparatus and apparatus for use in erecting temporary guard rails
Inventor: KUENZEL RAINER
IPC: B21D53/00
Filed: 2005-07-08
Abstract: A clamping apparatus for clamping the edge of a structure 10 with opposed surfaces 10A, 10B comprises a stanchion 17, a first clamping assembly 24 attached to the stanchion 17, and a second clamping assembly slideable along the stanchion 17. The second clamping assembly comprises a first collar 30A with a first frame 32 attached and slideable along the stanchion, a force imparting assembly 46 attached to the first frame 32, and a second collar 30B with a rotatably connected second frame and slideable along the stanchion. The second collar is positioned between the first collar and the first clamping assembly. The second frame comprises a support plate 58 extending laterally away from the stanchion 17 and a bearing plate 56 spaced away from but connected to the support plate 58. When the structure 10 is clamped between the first and second clamping assemblies, the support plate 58 will be adjacent one of the opposed surfaces of the structure. The force imparting assembly 46 acts on the bearing plate 56 to force the support plate 58 into compressive engagement with the surface 10A of the structure 10. The apparatus allows the quick erection of temporary guard rail supports 16.
Patent NZ-552673-A (NZ)
Title: A stable pharmaceutical composition comprising gabapentin
Inventor: RAMPOLDI LUCA
IPC: A61K9/14
Filed: 2005-07-19
Abstract: Provided is a stable pharmaceutical composition comprising gabapentin as active ingredient, wherein it also comprises a mixture of excipients capable of not promoting the conversion of gabapentin into the corresponding lactamic impurity, which comprises: (i) a sliding agent selected from a calcium salt of a weak acid, (ii) a lubricating agent selected from hydrogenated castor oil and glyceryl behenate; and optionally (iii) a diluting agent, alone or mixed with one or more other diluting agents, selected from monosaccharidic sugars and polysaccharidic derivatives. The composition can be used to prepare medical capsules.
Patent NZ-554206-A (NZ)
Title: 4-hydroxy tamoxifen gel formulations
Inventor: MASINI-ETEVE VALERIE
IPC: A61K9/06
Filed: 2005-10-13
Abstract: Disclosed is a pharmaceutical composition comprising: 0.205-0.950 % of 4-hydroxy tamoxifen, 50-75% of at least one C2-C6 alcohol, 0.1-5.0% of at least one gelling agent, 0.1-5.0% of at least one penetration enhancer, 20-50% of an aqueous vehicle, wherein percentages (%) are weight to weight of the composition. Also disclosed is a process for preparing the above composition comprising the steps of preparing a mixture containing at least one C2-C6 alcohol, and at least one penetration enhancer; adding 4-hydroxy tamoxifen in the desired amount and mixing; adding at least one gelling agent and mixing again; adding at lest one aqueous vehicle and mixing again. Also disclosed is the suitability for use of the above composition for treating and/or preventing benign breast diseases, scars and keloids, gynecomastia, breast cancer, mastalgia, and condition involving dense breast tissue.
Patent NZ-561067-A (NZ)
Title: Novelty container simulating person, animal or cartoon character, with closure head and feet
Inventor: LINDSAY BRENDAN JON
Filed: 2007-08-30
Abstract: Disclosed is a novelty container, typically for children, simulating a person, animal or cartoon character with a closure simulating head or headgear, and a base in the form of feet so that the container can stand upright.
Patent NZ-562713-A (NZ)
Title: Utility scale method and apparatus to convert low temperature thermal energy to electricity
Inventor: BAKER M DAVID
IPC: F24S90/00
Filed: 2006-03-23
Abstract: Methods and systems are disclosed to convert low temperature thermal energy to electricity. An apparatus disclosed includes an electrical generating unit to receive heat energy to produce electricity, a concentrator including a heat engine, a liquid piston operatively coupled to the heat engine, and a heat pump operatively coupled to the liquid piston, the heat engine adapted to collect thermal energy, and the heat pump operatively coupled to the electrical generating unit to provide heat to the electrical generating unit. The example apparatus also includes a heat engine floating piston disposed in the heat engine, a heat pump floating piston disposed in the heat pump, and wherein the heat engine floating piston and the heat pump floating piston oscillate.
Patent NZ-564753-A (NZ)
Title: Foodstuff
Inventor: NIELSEN JENS MOGENS
Filed: 2006-07-03
Abstract: Disclosed is a foodstuff comprising: (a) a first food material layer; (b) a colour migration barrier layer; (c) a second food material layer, wherein the colour migration barrier layer is disposed between the first food material layer and the second food material layer and is an edible liquid oil composition comprising: (i) an oil component; and (ii) a fat, emulsifier, wax or mixture thereof, having a melting point of greater than 55°C; wherein the oil component (i) has a solid fat content (N-value) at 20°C of less than 20.
Patent NZ-569428-A (NZ)
Title: Treatment of conditions involving demyelination with a Sp35 antagonist
Inventor: MI SHA
IPC: A61K39/00
Filed: 2006-12-01
Abstract: Disclosed is an in vitro method for promoting survival of an oligodendrocyte, the method comprising contacting an oligodendrocyte with an effective amount of a composition comprising an Sp35 antagonist selected from the group consisting of: (i) a soluble Sp35 polypeptide that lacks an Sp35 immunoglobulin (Ig) domain; (ii) an Sp35 antibody or antigen binding fragment thereof; and (iii) a combination of two or more of the Sp35 antagonists, wherein said method inhibits the binding of an Sp35 polypeptide with an ErbB2 polypeptide or wherein said method increases ErbB2 phosphorylation. Also disclosed is the Use of an Sp35 antagonist selected from the group consisting of: (i) a soluble Sp35 polypeptide that lacks an Sp35 immunoglobulin (Ig) domain; (ii) an Sp35 antibody or antigenbinding fragment thereof; and (iii) a combination of two or more of the Sp35 antagonists, and an ErbB2 binding agent selected from the group consisting of: (i) a soluble ErbB2 polypeptide; (ii) an ErbB2 antibody or antigen-binding fragment thereof; (iii) an ErbB2 polynucleotide which encodes a soluble ErbB2 polypeptide; and (iv) a combination of two or more of the ErbB2 binding agents, in the preparation of a medicament for treating a disease, disorder or injury associated with oligodendrocyte death, wherein said medicament is formulated to provide sequential administration or co-administration of the Sp35 antagonist and the ErbB2 binding agent.
Patent NZ-570939-A (NZ)
Title: Method and apparatus for universal improvement of vision
Inventor: GRIERSON JONATHAN
IPC: A61B18/20
Filed: 2007-03-08
Abstract: An optical lens is disclosed. The optical lens has anterior and posterior surfaces and an optical center on its anterior surface. The anterior surface has an M-wave shape such that the surface curvature measured along a curve passing through the optical center varies substantially as a smoothed letter M in relationship to angular orientation about the optical center. 0 degrees angular orientation is substantially the point closest to the nose when the lens is worn and the central dip of the M occurs substantially at a point which is furthest from the nose when the lens is worn, corresponding to a 180 degree orientation, there being maxima of the M at substantially the uppermost and lowermost vertical extremes of the lens when it is worn, to 90 degree and 270 degree orientations, respectively. The surface curvature measured along a curve passing through the optical center is the surface curvature that is determined along a half meridian from a point on the perimeter of the cornea to a central point on the cornea.
Patent NZ-573176-A (NZ)
Title: CRYSTAL STRUCTURE OF CRIg AND C3b:CRIg COMPLEX
Inventor: KATSCHKE KENNETH JR
IPC: C07K14/435
Filed: 2007-05-30
Abstract: Disclosed in the crystal structure of the marcrophage specific receptor (CRIg) having the amino acid sequence SEQ ID NO: 2. Also disclosed is the crystal structures of CRIg in complex with the C3b and C3c subunits of the complement C3 protein. The crystal structures are used to identify CRIg agonists that mimics the C3b binding.
Patent NZ-574896-A (NZ)
Title: Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
Inventor: GOODYEAR MARK DAVIS
IPC: A61K39/02
Filed: 2007-08-30
Abstract: Disclosed is a vaccine comprising an emulsion and a heat treated Leptospira bacterin comprising a suspension of killed Leptospira bacteria which have a lipase activity of 50 percent or less than the lipase activity of the bacterin before the heat treatment, and which have acceptable antigenic activity. The killed Leptospira bacteria are one to five Leptospira species selected from the group consisting of Leptospira amicola, Leptospira grippotyposa, Leptospira hardjo, Leptospira icterohaemorrhagiae, and Leptospira Pomona. Also disclosed are methods for producing the vaccine.
Patent NZ-580956-A (NZ)
Title: Process for preparing exemestane, an aromatase inhibitor
Inventor: CHEN WEIYU
IPC: C07J1/00
Filed: 2008-05-01
Abstract: Disclosed herein is a process of making an aromatase inhibitor of formula (I), wherein each of R1-R4, independently, is hydrogen, halogen, or C1-C6 alkyl, the process comprising reading a compound of formula (II), wherein R1-R4 is as defined above, and R is methylene, with an acid in the presence of a solvent at a temperature of 60-90°C to produce the aromatase inhibitor of formula (I), wherein the solvent is an organic solvent selected from the group consisting of toluene, benzene, xylenes, ethyl acetate, methyl isobutyl and mixtures thereof.
Patent NZ-585357-A (NZ)
Title: Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
Inventor: KONAKANCHI DURGA PRASAD
IPC: C07D401/14
Filed: 2008-10-28
Abstract: Disclosed are 4-(tetrazol-5-yl)-quinazoline derivatives represented by general formula (I). Processes for making the compounds are disclosed as well as the use of the compounds of formula (I) for treating cancer.
Patent NZ-585514-A (NZ)
Title: Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
Inventor: MAGGI CARLO ALBERTO
IPC: A61K38/08
Filed: 2008-11-10
Abstract: Disclosed are pharmaceutical compositions comprising a mixture of hyaluronic acid and a bradykinin B2 receptor antagonist, wherein the bradykinin antagonist is selected from; H-D-Arg-Arg-Pro-Hyp-Gly-Igl-Ser-D-F5F-Igl-Arg-OH H-Arg-Arg-Pro-Hyp-Gly-Igl-Ser-D-Igl-Oic-Arg-OH H-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg-OH (Icatibant) 4-[2-[([[3-(3-Brom-2-methyl-imidazo[1.2-a]pyridine-8-yl oxymethyl)-2,4-dichloro-phenyl]-methyl-carbamoyl]-methyl)carbamoyl]-vinyl]-N,N-dimethyl-benzamide, 3-(6-Acetylamino-pyridine-3-yl)-N-([[2,4-dichloro-3-(2-methyl-quinoline-8-yl oxymethyl)-phenyl]-methyl-carbamoyl]-methyl)acrylamide, 1-[2,4-Dichloro-3-(2,4-dimethyl-quinoline-8-yl oxymethyl)-benzene sulphonyl]-pyrrolidine-2-carboxylic acid [3-(4-carbamidoyl-benzoylamino)-propyl]-amide (Anatibant) 4-(4- [1-[2,4-Dichloro-3-(2,4-dimethyl-quinoline-8-yl oxymethyl)-benzene sulphonyl]-pyrrolidine-2-carbonyl]-piperazine-1-carbonyl)-benzamidine, 2-[5-(4-Cyano-benzoyl)-1-methyl-1H-pyrrol-2-yl]-N-[2,4-dicloror-3-(2-methyl-quinoline-8-yl oxymethyl)-phenyl]-N-methyl-acetamide; or A compound of formula (I), wherein the substituents are disclosed within the specification.
Patent NZ-594375-A (NZ)
Title: A unit for and method of neutralising washout from concreting operations
Inventor: COULTON RICHARD HENRY
IPC: C02F1/66
Filed: 2010-01-19
Abstract: 594375 A method of neutralising washout from concreting operations comprises the steps of : providing a portable unit (10) to contain the washout, providing the unit with a store of a neutralising agent, receiving the washout in a washout receiving region (20) of the unit, and transferring a washwater component from the washout receiving region of the unit to a washwater containment region (14) of the unit whilst retaining solids in the washout receiving region, and supplying the neutralising agent to the washout in the washwater containment region of the unit.
Patent NZ-594812-A (NZ)
Title: Nucleotides and nucleosides and methods for their use in dna sequencing
Inventor: LITOSH VLADISLAV A
IPC: C07H19/14
Filed: 2009-06-11
Abstract: Provided is a compound (C) or (D) in the drawing, with defined substituents. The compound can be linked to a dye reported molecule and methods of polynucleotide sequencing using the compounds are also provided. The reporter molecules can be various ALEXA FLUOR dyes.
Patent NZ-599596-A (NZ)
Title: Rational design of regenerative medicine products
Inventor: RAPOPORT H SCOTT
IPC: G01N33/50
Filed: 2010-11-12
Abstract: Patent No. 599596 Disclosed is a method for identifying inputs necessary to elicit a regenerative response in a target tissue in need of regeneration, comprising (a) identifying functional elements of a healthy reference tissue or organ that is the same as the target tissue or organ; (b) identifying functional deficits or abnormalities associated with the target tissue or organ; (c) isolating the functional elements of the reference tissue or organ, individually or as controlled admixtures; (d) creating a core list of putative inputs representing a plurality of functional elements is identified in step (a) wherein said list comprises cell, biomaterial and bioactive molecule elements; (e) creating a test grid comprising all combinations of putative inputs from the core list; (f) conducting in vivo experiments in non-human mammals based on the test grid to ascertain the target tissue or organ functional response to the combinations tested; and (g) based on the results of the in vivo experiments, identifying the inputs capable of modulating a regenerative response in the target tissue or organ.
Patent NZ-602432-A (NZ)
Title: Safety can
Inventor: CARTER GLEN
IPC: B67D3/00
Filed: 2011-03-01
Abstract: A can for storing and dispensing liquids such as gasoline (petrol) or oil includes a valve assembly with a fill cap 204 and a pour valve 242, 244, 224. The valve body 202 of the valve assembly defines a fill opening 220, a pour opening 224, a main passage 252 and a pouring valve passage 224. The main passage 252 extends along a main passage centreline 258 between the fill opening that can be closed by the fill cap and the main opening 18 in the top of the receptacle of the can. The pour opening 224 is located substantially perpendicular to the main passage 220 and the pouring valve passage is in communication with the pour opening and with the main passage via the fluid passage 262. The pour valve 240 is movably disposed within the pouring valve passage between a closed and an open position, and is biased closed by the spring 230 but may be opening by the user pulling on pull 228. The pour valve fluidly blocks the pour opening when the pour valve is in a closed position. The main passage centreline 258 is disposed at an offset distance (D) from the pouring valve passage centreline along an axis that is perpendicular to the pouring valve passage centreline.
Patent NZ-612836-A (NZ)
Title: Plasminogen and plasmin variants
Inventor: ZWAAL RICHARD REINIER
IPC: C12N9/68
Filed: 2012-01-04
Abstract: Disclosed is an isolated plasminogen variant or plasmin obtained from it, or an isolated plasmin variant, or a proteolytically active or reversible inactive derivative of any of the plasmins characterised in that: it comprises in its catalytic domain a mutation of the amino acid glutamate at position 138 of the human plasmin catalytic domain, or of the corresponding amino acid residue of a non-human plasmin catalytic domain. Also disclosed is a method for screening for an autoproteolytically stable plasmin variant.
Patent NZ-614674-A (NZ)
Title: Apparatus, system and method for a solar panel safety switch
Inventor: ADAM CHARLES SARGENT
IPC: H01L31/042
Filed: 2013-08-23
Abstract: 614674 Disclosed is a device (101) for use with one or more solar power generating panels. The device (101) has a switch (105) for controlling an electricity supply from an electricity supplying output of at least one of the one or more solar power generating panels to an inverter. When a predetermined condition is met or maintained, the electricity supplying output is substantially electrically shorted without grounding and at least a part of the inverter for receiving the electricity supply is disconnected from the electricity supplying output of the at least one or more solar power generating panels.
Patent NZ-616207-A (NZ)
Title: Beverage/food product preparation systems
Inventor: HANSEN NICK ANDREW
IPC: A47J31/44
Filed: 2012-03-30
Abstract: This disclosure relates to improvements in beverage/food product preparation systems and in particular to beverage/food product preparation systems comprising machines of the type which use pre-packaged cartridges containing beverage or food ingredients. The cartridge (30) contains one or more beverage or food ingredients for use in a machine for preparing a beverage or food product from said ingredients. The cartridge (30) comprises a base (34), an outlet aperture (37) in the base (34), and a collar (38) extending from the cartridge base (34) around the outlet aperture (37). The cartridge (30) is inserted into a holding receptacle (14) of a machine the collar (38) interacts with an element (65) of the machine and the collar (38) is configured to determine the pressure in the cartridge (30) during the preparation process.
Patent NZ-618358-A (NZ)
Title: Wind energy plant tower
Inventor: BRENNER ALBRECHT
IPC: E04H12/34
Filed: 2012-06-07
Abstract: A wind power installation pylon comprising a plurality of pylon segments which respectively have an upper and a lower horizontal flange and a peripheral surface. At least one of the plurality of the pylon segments has at least two longitudinal flanges 130.Each longitudinal flange has a first side for bearing against a first side of a further longitudinal flange and a second side to which the peripheral surface is welded, wherein the second side is opposite to the first side.
Patent NZ-630385-A (NZ)
Title: Beta-hydroxy-beta-methylbutyric acid for improving glucose tolerance
Inventor: SATHYAVAGEESWARAN SHREERAM
IPC: A61P3/10
Filed: 2013-03-18
Abstract: Disclosed is the use of beta-hydroxy-beta-methylbutyric acid (HBM) in the manufacture of a medicament for improving glucose tolerance and insulin resistance in a prediabetic individual or other potential prediabetics to prevent or delay the development of diabetes. In certain embodiments, the beta-hydroxy-beta-methylbutyric acid is administered via a nutritional composition. HBM is also known as beta-hydroxy beta-methylbutyrate, 3-hydroxy-3-methylbutanoic acid, beta-Hydroxyisovaleric acid, or 3-Hydroxyisovaleric acid.
Patent NZ-707255-A (NZ)
Title: Towing assembly
Inventor: HELLAND CHAD LEIGHTON
IPC: B60D1/54
Filed: 2012-04-02
Abstract: A towing assembly (1) that can convert from an articulated assembly to a rigid assembly for safely towing a vehicle on a road is disclosed. Assemblies for towing vehicles require many, often competing functions. As in many designs, in order to maximize the functionality of one operation there is often a concomitant reduction in the functionality of another operation. For example, in order to extract vehicles from an inaccessible location, such as a ditch, it is preferable to have a supple and flexible assembly to reach the ditched vehicle. Such assemblies are often woven fabric, multi-strand cable, or other substantially tensile structures. However, after extraction, when towing the vehicle on a road, it is preferable to have a rigid assembly to more securely affix the towed vehicle to the towing vehicle. Such assemblies are often of rigid triangular shape. However, such rigid assemblies, although safer for towing on the road, are of far less use in the extraction process. There is therefore a great need in the art for a towing assembly that can both reach difficult locations and still safely tow the extracted vehicle. The articulating towing assembly comprises a hitch (2) and a pair of members (4a, 4b) attached to the hitch. Each pair of members has two shafts (8,10) and a locking joint (12) between them. Each of the members can be locked for rigidly securing the orientation thereof with respect to the hitch.
Patent NZ-710491-A (NZ)
Title: Grinder for grinding coffee beans as well as coffee machine comprising such a grinder
Inventor: STEPHAN PROBST
IPC: A47J31/42
Filed: 2015-07-30
Abstract: What is described is a new grinder (1), which serves to grind coffee beans (3) and which is embodied as conical grinder. To improve the grinding process, the grinding cones (11) and/or grinding ring (15) encompass grinding surfaces (64, 69, 94, 99) comprising an angle of inclination (φ), which is in each case greater than 90° and smaller than 180°, relative to a tool reference plane (E-I). A benefit of this conical geometry design is that the beans are cut finely but that noise during operation is reduced. (Fig. 6E)
Patent NZ-714107-A (NZ)
Title: Improved methods for processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12P19/14
Filed: 2012-12-20
Abstract: Disclosed are methods for processing biomass materials that are disposed in one or more porous structures or carriers, e.g., a bag, a shell, a net, a membrane, a mesh or any combination of these. Containing the material in this manner allows it to be readily added or removed at any point and in any sequence during processing. Also disclosed is the addition of an additive such as, e.g., microorganism, a nutrient, a spore, an enzyme, an acid, a base, a gas, an antibiotic, or a pharmaceutical to the structure or carrier to convert the contained biomass into useful products.
Patent NZ-733125-A (NZ)
Title: Isoquinoline compounds for the treatment of hiv
Inventor: HU YUNFENG
IPC: C07D401/12
Filed: 2015-12-23
Abstract: Described herein are compounds of Formula (I) and tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, use of the compounds in the treatment or prevention an HIV infection and methods of making such compounds.
Patent NZ-748983-A (NZ)
Title: Antibodies specific for hyperphosphorylated tau and methods of use thereof
Inventor: PEDERSEN JAN
IPC: A61K39/00
Filed: 2017-07-07
Abstract: The present invention relates to a class of monoclonal antibody that specifically binds the phosphorylated serine 396 residue on pathological hyperphosphorylated (PHF) tau (pS396) with improved affinity, as well as to methods of using these molecules and their tau binding fragments in the treatment of Alzheimer s disease and other tauopathies.
Patent NZ-750627-A (NZ)
Title: Defined microbial compositions
Inventor: WAGNER D
IPC: C05F11/08
Filed: 2017-08-30
Abstract: Disclosed herein are compositions including cells of defined sets of microbial species (for example, 3, 16, 18, 19, 21, or 22 microbial species). Also disclosed are methods of using the microbial compositions that include contacting soil, plants, plant parts, or seeds with the composition. The microbial compositions are also used in methods of degrading biological materials, such as chitin-containing biological materials. A specific embodiment of the invention is a composition comprising cells of microbial species including or consisting of each of microbial species each having one of16s rDNA SEQ ID NOs: 3-24.